Govt asks manufacturers to cut price of 3 anti-cancer drugs

The government has directed manufacturers to lower prices of Trastuzumab, Osimertinib, and Durvalumab after exempting them from customs duty and reducing GST. This measure aims to ensure affordable anti-cancer drugs for consumers. Companies must update and report new prices to authorities and dealers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/L8xRb4u
via IFTTT